Longevity Research Insights

A recent gathering at the Buck Institute highlighted the growing interest in biomarkers related to aging, emphasizing the need for causative measures. As billionaires invest in longevity research, the conversation shifts towards practical applications, such as the effects of diet on health. The discussion also delves into the controversial use of metformin, a diabetes drug that many are exploring for its potential longevity benefits, raising important questions about its efficacy and safety.